Updated:
The McKay Institute
The McKay Institute invests at the intersection of oncology care and private equity, targeting growth and venture-stage companies in community cancer care.
The McKay Institute
The McKay Institute functions as a specialized investment platform focused on oncology, maintaining offices in New York, Boston, and Nashville. The firm targets growth-stage and venture opportunities within the cancer-care ecosystem, a strategy that distinguishes it from generalist healthcare funds. Investment activity concentrates on companies that support community oncology — the network of independent practices that deliver the majority of US cancer care outside academic medical centers. The firm deploys capital across healthcare services, digital health tools, enterprise software for practice management, and AI/ML applications in clinical workflows. The geographic focus is primarily the United States, where the community oncology model faces consolidation pressure and technology-driven transformation. Operational details, including total deployment, team size, and named principals, are not publicly disclosed. The firm's web presence at tnoncology.com points to a closely held structure, with no LinkedIn profile currently captured. The absence of publicly named leadership or specific portfolio companies limits visibility into the firm's track record and governance. The structural differentiator is the firm's thesis-level commitment to oncology economics rather than a general healthcare mandate. By concentrating exclusively on the financial and operational infrastructure of cancer care, The McKay Institute occupies a narrow lane that few dedicated investment platforms publicly claim. This focus suggests a network-driven sourcing model tied to clinical operators and practice administrators rather than traditional GP-led deal flow.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Additional offices
Nashville, TN · Boston, MA
Sector focus
Frequently asked questions
What does The McKay Institute invest in?
The McKay Institute targets growth and venture-stage companies within the oncology ecosystem. Its investment thesis centers on community oncology — the independent cancer-care practices that treat the majority of US patients outside academic hospitals. The firm's sector reach includes healthcare services, digital health, practice-management software, and AI/ML applications deployed in clinical cancer-care workflows.
How is The McKay Institute structured?
The firm operates as a specialized private equity platform with offices in New York, Boston, and Nashville. It is not structured as a family office but as an asset manager focused on a single therapeutic area. The firm's website at tnoncology.com reflects this oncology-specific mandate, though the ownership and governance structure remain private.
Who runs investment decisions at The McKay Institute?
Named principals and the firm's investment committee composition are not publicly disclosed. The firm maintains a low public profile with no LinkedIn page and limited web presence as of mid-2026, which is consistent with a closely held investment vehicle that sources deals through clinical and operational networks rather than public marketing.
What is the firm's approach to community oncology?
Community oncology practices face distinct economic pressures: reimbursement complexity, drug-pricing volatility, and consolidation by hospital systems. The McKay Institute appears to invest in companies that provide the operational infrastructure, technology, and services that help these independent practices remain financially viable outside large health systems.
Does The McKay Institute participate in fund commitments or only direct deals?
The firm's investment structure — whether it operates via direct co-investments, SPVs, or committed fund vehicles — has not been publicly described. Based on the firm's narrow oncology mandate, direct or co-investment structures are the most common vehicles for thesis-driven specialist platforms of this type.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: